Spearhead Capital Advisors’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,795
| Closed | -$256K | – | 135 |
|
|
2022
Q2 | $256K | Sell |
1,795
-480
| -21% | -$68.5K | 0.04% | 138 |
|
|
2022
Q1 | $392K | Buy |
2,275
+744
| +49% | +$128K | 0.05% | 105 |
|
|
2021
Q4 | $389K | Buy |
1,531
+5
| +0.3% | +$1.27K | 0.05% | 124 |
|
|
2021
Q3 | $587K | Sell |
1,526
-57
| -4% | -$21.9K | 0.08% | 84 |
|
|
2021
Q2 | $372K | Sell |
1,583
-2,771
| -64% | -$651K | 0.05% | 156 |
|
|
2021
Q1 | $570K | Buy |
4,354
+131
| +3% | +$17.2K | 0.08% | 77 |
|
|
2020
Q4 | $441K | Sell |
4,223
-671
| -14% | -$70.1K | 0.07% | 111 |
|
|
2020
Q3 | $346K | Sell |
4,894
-20
| -0.4% | -$1.41K | 0.07% | 112 |
|
|
2020
Q2 | $316K | Sell |
4,914
-3,948
| -45% | -$254K | 0.07% | 97 |
|
|
2020
Q1 | $265K | Buy |
+8,862
| New | +$265K | 0.08% | 88 |
|